Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC DATABASE   /   MOBILE APP  /  CELEBRITY VCs   /   VENTURE TRACKR   /   ARCHIVE   /   ABOUT US
VC-funded Company:


StrideBio
701 West Main Street, Suite 200
Durham, NC 27701
Phone: 302-290-5544
http://www.stridebio.com/

StrideBio, Inc is a gene therapy company focused on creating and developing novel adeno-associated viral (AAV) vector technologies and therapeutics for rare diseases. Our STRucture Inspired DEsign approach holds the potential to generate unique AAV capsids capable of overcoming the challenges of pre-existing neutralizing antibodies and improving gene transfer efficiency in patients. This powerful new approach has broad application, enabling gene addition, gene silencing and gene editing modalities for a wide range of diseases, including rare genetic diseases.

Key Contact
NameTitleE-Mail
Patrick RitschelPresidentpRitschel@stridebio.com


Funding Events
DateAmountTypeInvestors
06/13/18$15,700,000Series A Alexandria Real Estate Equities
Hatteras Venture Partners  
Takeda Ventures
UCB
 
Massinvestor/VC News Daily
617-620-4606


© 2018 Massinvestor, Inc.